ANTICANCER TREATMENTS
PEGYLATED LIPOSOMAL DOXORUBICIN IN COMBINATION WITH ECTEINESCIDIN 743
Publication number: NO20072543
Publication date: 2007-07-13
Inventor: GILLES ERARD (US); STERNAS LARS-AXEL (US); TRIFAN OVID (US); VELDE HELGI VAN DE (BE); TEITELBAUM APRIL (US)
Applicant: ORTHO BIOTECH PRODUCTS LP (US)
Classification:
- international: A61K31/495; A61K31/351; A61P35/00; A61K31/495; A61K31/351; A61P35/00;
- European: A61K47/48W6D
Application number: NO20070002543 20070516
Priority number(s): US20040622163P 20041026; WO2005GB50189 20051026
Abstract not available for NO20072543
Abstract of corresponding document: WO2006046080
A method of treating the human body for cancer comprises administering an effective therapeutic amount of a Pegylated Liposomal form of the anthracycline Doxorubicin ("PLD"), in combination with an effective therapeutic amount of ET-743